Table 1.
Patients’ characteristics
| Training | ||||
|---|---|---|---|---|
| ATStandard | ATPolarized | RTStandard | RTUndulating | |
| Type of cancer, n (%) | ||||
|
Breast cancer Prostate cancer |
15 (53.6) 13 (46.4) |
12 (46.2) 14 (53.8) |
16 (61.5) 10 (38.5) |
13 (48.1) 14 (51.9) |
| Age [years], mean ± SD | 59 ± 10 | 60 ± 8 | 55 ± 11 | 61 ± 10 |
| BMI [kg/m2], mean ± SD | 27.47 ± 5.49 | 27.38 ± 5.07 | 26.90 ± 4.65 | 26.60 ± 4.07 |
| Time since diagnosis [months], mean ± SD | 13 ± 7 | 21 ± 19 | 27 ± 38 | 17 ± 15 |
| Time since end of therapy [wk], mean ± SD | 23 ± 14 | 25 ± 12 | 27 ± 20 | 28 ± 14 |
| Tumor staging, n (%) | ||||
|
0 I II III IV Unclear |
0 (0) 10 (35.7) 11 (39.3) 6 (21.4) 0 (0) 1 (3.6) |
0 (0) 13 (50) 4 (15.4) 7 (26.9) 0 (0) 2 (7.7) |
0 (0) 12 (46.2) 6 (23.1) 7 (26.9) 1 (3.8) 0 (0) |
0 (0) 13 (48.1) 11 (40.7) 2 (7.4) 0 (0) 1 (3.7) |
| Cancer treatment, n (%) | ||||
|
Surgery alone Radio therapy alone Surgery + radio therapy Surgery + radio therapy + chemotherapy Additional hormone therapy Additional antibody therapy Unknown |
6 (21.4) 1 (3.6) 10 (35.7) 9 (32.1) 15 (53.6) 5 (17.9) 2 (7.2) |
2 (7.7) 4 (15.4) 14 (53.8) 4 (15.4) 15 (57.7) 2 (7.7) 2 (7.7) |
4 (15.4) 1 (3.8) 9 (34.6) 11 (42.3) 15 (57.7) 5 (19.2) 1 (3.8) |
7 (25.9) 4 (14.8) 9 (33.3) 6 (22.2) 13 (48.1) 2 (7.4) 1 (3.7) |
No significant between group differences for type of cancer, age, BMI, time since diagnosis and time since end of therapy were found (BMI, body-mass-index)